Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy

Tumor-treating fields (TTFields) are alternating electric fields in a specific frequency range (100–300 kHz) delivered to the human body through transducer arrays. In this study, we evaluated whether TTFields-mediated cell death can elicit antitumoral immunity and hence would be effectively combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Voloshin, Tali, Kaynan, Noa, Davidi, Shiri, Porat, Yaara, Shteingauz, Anna, Schneiderman, Rosa S., Zeevi, Einav, Munster, Mijal, Blat, Roni, Tempel Brami, Catherine, Cahal, Shay, Itzhaki, Aviran, Giladi, Moshe, Kirson, Eilon D., Weinberg, Uri, Kinzel, Adrian, Palti, Yoram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303058/
https://www.ncbi.nlm.nih.gov/pubmed/32144446
http://dx.doi.org/10.1007/s00262-020-02534-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303058/
https://www.ncbi.nlm.nih.gov/pubmed/32144446
http://dx.doi.org/10.1007/s00262-020-02534-7

Ejemplares similares